Lippman M E, Dickson R B
Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC 20007.
J Steroid Biochem. 1989;34(1-6):107-21. doi: 10.1016/0022-4731(89)90071-x.
In this presentation we review information highlighting the multiple roles of both steroidal and polypeptide regulators of mammary epithelial cell growth with some additional emphasis on the work of our laboratory. The effects of both classes of hormones are complex and involve multiple interactions with epithelial components (malignant or normal) and the stromal compartment. Estrogens induce growth regulatory polypeptide growth factors which are responsible for many of the induced phenotypic effects in hormone-dependent breast cancer. Progression of hormone-dependent breast cancer to hormone independence probably involves multiple genetic mechanisms of oncogene activation, loss of the estrogen receptor, or loss of hormone responsivity of other gene products. Initial carcinogenesis and progression of mammary epithelium to cancer probably also requires both proliferative stimuli (estrogen, polypeptide growth factors) and genetic damage, leading to qualitatively different hormonal responses (hormone responsive cancer). New therapeutic strategies based on these biological considerations are emerging, including a variety of approaches which interfere at multiple points with ability of ligand to induce receptor signaling.
在本报告中,我们回顾了相关信息,这些信息突出了甾体和多肽类乳腺上皮细胞生长调节因子的多种作用,并特别强调了我们实验室的工作。这两类激素的作用都很复杂,涉及与上皮成分(恶性或正常)和间质成分的多种相互作用。雌激素诱导生长调节多肽生长因子,这些因子负责激素依赖性乳腺癌中许多诱导的表型效应。激素依赖性乳腺癌向激素非依赖性的进展可能涉及癌基因激活、雌激素受体丧失或其他基因产物激素反应性丧失的多种遗传机制。乳腺上皮细胞的初始致癌作用和向癌症的进展可能也需要增殖刺激(雌激素、多肽生长因子)和基因损伤,从而导致性质不同的激素反应(激素反应性癌症)。基于这些生物学考虑的新治疗策略正在出现,包括多种在多个点干扰配体诱导受体信号传导能力的方法。